Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Hong

Showing results (181-190 of 442) with videos related to

Pageof 45
Sort By:
Journal of Neurointerventional Surgery|May 7, 2026
Balloon guide catheters improve first-pass effect and neurologic outcomes in mechanical thrombectomy: a matched cohort analysisGnaneswari Karayi, Joshua R Feler, Revyn Kim, et al.
The Oncologist|June 10, 2015
The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody CixutumumabNaifa L Busaidy, Patricia LoRusso, Kristie Lawhorn, et al.
Radiology|April 19, 2017
Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body ImagersVeronica L Cox, Priya Bhosale, Gauri R Varadhachary, et al.
Investigational New Drugs|November 26, 2019
Factors affecting symptom presentation in an early-phase clinical trials clinic patient populationGoldy C George, Tito R Mendoza, Eucharia C Iwuanyanwu, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2018
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvementElena Fountzilas, Elangovan Krishnan, Filip Janku, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2012
Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesotheliomaDaniel R Gomez, David S Hong, Pamela K Allen, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2013
Factors related to biopsy willingness in patients with advanced cancer in a phase 1 clinic for molecularly targeted therapyDavid S Hong, Goldy C George, Eucharia C Iwuanyanwu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 15, 2023
Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic diseaseKewen He, David S Hong, Chad Tang, et al.
Journal of the National Cancer Institute|September 18, 2015
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA ApprovalDenis L Jardim, Denis L Fontes Jardim, Maria Schwaederle, et al.
Investigational New Drugs|March 31, 2015
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancerDavid S Hong, Filip Janku, Aung Naing, et al.
Pageof 45

Showing results (181-190 of 442) with videos related to

Sort By:
Pageof 45
Journal of Neurointerventional Surgery|May 7, 2026
Balloon guide catheters improve first-pass effect and neurologic outcomes in mechanical thrombectomy: a matched cohort analysisGnaneswari Karayi, Joshua R Feler, Revyn Kim, et al.
The Oncologist|June 10, 2015
The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody CixutumumabNaifa L Busaidy, Patricia LoRusso, Kristie Lawhorn, et al.
Radiology|April 19, 2017
Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body ImagersVeronica L Cox, Priya Bhosale, Gauri R Varadhachary, et al.
Investigational New Drugs|November 26, 2019
Factors affecting symptom presentation in an early-phase clinical trials clinic patient populationGoldy C George, Tito R Mendoza, Eucharia C Iwuanyanwu, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2018
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvementElena Fountzilas, Elangovan Krishnan, Filip Janku, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2012
Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesotheliomaDaniel R Gomez, David S Hong, Pamela K Allen, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2013
Factors related to biopsy willingness in patients with advanced cancer in a phase 1 clinic for molecularly targeted therapyDavid S Hong, Goldy C George, Eucharia C Iwuanyanwu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 15, 2023
Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic diseaseKewen He, David S Hong, Chad Tang, et al.
Journal of the National Cancer Institute|September 18, 2015
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA ApprovalDenis L Jardim, Denis L Fontes Jardim, Maria Schwaederle, et al.
Investigational New Drugs|March 31, 2015
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancerDavid S Hong, Filip Janku, Aung Naing, et al.
Pageof 45